JP4463300B2 - Subject management method and apparatus - Google Patents
Subject management method and apparatus Download PDFInfo
- Publication number
- JP4463300B2 JP4463300B2 JP2007292378A JP2007292378A JP4463300B2 JP 4463300 B2 JP4463300 B2 JP 4463300B2 JP 2007292378 A JP2007292378 A JP 2007292378A JP 2007292378 A JP2007292378 A JP 2007292378A JP 4463300 B2 JP4463300 B2 JP 4463300B2
- Authority
- JP
- Japan
- Prior art keywords
- subject
- computer
- diary
- entry
- mediator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000007726 management method Methods 0.000 title claims description 25
- 238000012360 testing method Methods 0.000 claims description 28
- 238000007619 statistical method Methods 0.000 claims description 15
- 238000011156 evaluation Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 8
- 230000003203 everyday effect Effects 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 235000012054 meals Nutrition 0.000 claims description 6
- 230000002354 daily effect Effects 0.000 claims description 5
- 230000003862 health status Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000000391 smoking effect Effects 0.000 claims description 5
- 230000035622 drinking Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
Landscapes
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Description
この発明は、食品、大衆薬などの医薬品、化粧品などの治験において、被験者による定期的な経過報告を確実に集めることができる被験者管理方法および装置に関するものである。 The present invention relates to a subject management method and apparatus capable of reliably collecting periodic progress reports by subjects in clinical trials for foods, pharmaceuticals such as popular drugs, cosmetics, and the like.
新しい食品特に健康食品、新しい大衆医薬品、新しい化粧品などでは、これらの有効性、安全性などを確認するため、治験の対象、目的などに応じて適切な治験者を選定して治験(臨床試験)を行っている。この治験は、食品、医薬品、化粧品などの開発者・販売者などの治験依頼者が直接治験実施者となって、または治験依頼者が決定した治験実施機関を治験実施者として被験者に対し種々の治験を行うものである。 In the case of new foods, especially health foods, new popular pharmaceuticals, and new cosmetics, in order to confirm their effectiveness and safety, appropriate investigators are selected according to the subject and purpose of the trial (clinical trial). It is carried out. The trial is conducted by a trial sponsor such as a developer, seller, etc. of food, pharmaceuticals, cosmetics, etc. directly as the trial investigator, or the trial investigator determined by the trial sponsor is used as a trial investigator. A clinical trial is conducted.
特許文献1にはインターネットを介して治験管理サーバと、治験依頼者端末と、治験実施者端末と、被験者端末とを接続し、互いにデータを交換できるようにすることが示されている。また治験依頼者と治験実施者と被験者が、ウェブを介して治験管理サーバの記憶装置に記憶されたデータを閲覧できるようにすることも示されている(段落0145,図9)。ここに被験者端末は、治験管理サーバに接続して情報を入手したり、他の治験依頼者や被験者との間でデータの送受信を行うことも示されている(段落0149)。 Patent Document 1 discloses that a clinical trial management server, a clinical trial requester terminal, a clinical trial investigator terminal, and a subject terminal are connected via the Internet so that data can be exchanged with each other. It is also shown that the trial client, the trial investigator, and the test subject can browse the data stored in the storage device of the trial management server via the web (paragraph 0145, FIG. 9). Here, it is also shown that the test subject terminal connects to a clinical trial management server to obtain information, and transmits / receives data to / from other trial requesters and test subjects (paragraph 0149).
このように治験実施者端末と被験者端末とをインターネットを介して接続することは公知であるが、この特許文献1ではデータの送受信を行うことが示されているだけであって、どのようなデータを送受信するかは不明である。またこの特許文献1の方法は、「治験の主役は患者であるという原則」に基づくものであり(段落0083,0084)、比較的重篤な患者を対象とするものと考えられる。すなわち患者(被験者)の地域にある開業医が持つ地域密着形医療体制を活かし、被験者の管理およびケアの実行のため被験者が必ず通院するようにしたものであるからである(段落0084〜0088,0099,0150,0155など)。 In this way, it is known to connect the trial investigator terminal and the subject terminal via the Internet, but this Patent Document 1 only shows that data is transmitted and received, and what kind of data Whether to send or receive is unknown. The method of Patent Document 1 is based on the “principle that the main role of the trial is a patient” (paragraphs 0083 and 0084), and is considered to be intended for relatively severe patients. That is, the community-based medical system of the practitioner in the area of the patient (subject) is used to ensure that the subject goes to the hospital for the management of the subject and the execution of care (paragraphs 0084-0088,0099). , 0150, 0155, etc.).
このため治験依頼者は治験可能と予想される治験実施者を直接訪問して調査する(段落0004)。また被験者の選出にあたっては、被験者と対面し会話を通して治験内容を十分に納得させたうえで同意を得るものである(段落0081,0083)。 For this reason, the sponsor will visit the investigator who is expected to be able to conduct the study and investigate (paragraph 0004). In selecting a subject, consent is obtained after confronting the subject and sufficiently convincing the content of the trial through conversation (paragraphs 0081 and 0083).
このような事情を考慮すると、この特許文献1に記載のものは、被験者端末と治験実施者端末との間で送受信するのは、投薬の指示・実行、通院の依頼・承諾などの情報が主体になるものと考えられる。しかしこの場合は個々の被験者に対して個別に指示・依頼をしなければならず、従来の電話や郵便による連絡を単にインターネットを介したeメールに変えたにすぎないものである。このため個々の被験者に対する管理が面倒であった。特に多数の被験者を対象とする治験、例えば健康食品、健康飲料、栄養補助食品(サプリメント)、化粧品などの治験では、通常健康に問題が無い人が被験者として選出されるから、頻繁に病院に通院する必要性に乏しく、このような場合に被験者を能率良く管理できるシステムの出現が望まれる。 In view of such circumstances, what is described in this Patent Document 1 is mainly sent and received between the subject terminal and the investigator terminal mainly on information such as medication instruction / execution and hospital request / consent. It is thought to become. In this case, however, individual subjects must be individually instructed and requested, and the conventional telephone or postal communication is merely changed to e-mail via the Internet. For this reason, management for each subject was troublesome. Especially in clinical trials involving a large number of subjects, such as health foods, health drinks, nutritional supplements (supplements), cosmetics, etc. Therefore, the emergence of a system that can efficiently manage subjects in such cases is desired.
この発明はこのような事情に鑑みなされたものであり、多数の被験者を能率良く管理することができるコンピュータを用いた被験者管理方法を提供することを第1の目的とする。またこの方法の実施に用いる装置を提供することを第2の目的とする。 This invention is made | formed in view of such a situation, and makes it the 1st objective to provide the test subject management method using the computer which can manage many test subjects efficiently. A second object is to provide an apparatus used for carrying out this method.
この発明によれば第1の目的は、治験依頼者の依頼に基づいて行う治験に協力する被験者を、インターネットを介して管理するためのコンピュータを用いた被験者管理方法であって、a.仲介者のコンピュータは治験依頼者の依頼内容に基づいて治験計画を作成すると共に被験者に食事内容、テスト品の摂取状況、喫煙・飲酒の有無、運動量、健康状態の変化の記入欄を設けた日誌フォーマットとスケジュールを作成し記憶する、b.仲介者のコンピュータはインターネットを介して仲介者のコンピュータに記憶した治験内容、日誌フォーマット、スケジュール、ID、PWを被験者のコンピュータに送る、c.被験者のコンピュータから前記日誌フォーマットの記入欄ごとに毎日入力される日誌入力情報の有無を仲介者のコンピュータが毎日確認し、未入力がある被験者のコンピュータに対して記入催促のメールを送る、d.仲介者のコンピュータは、多数の被験者が入力完了した日誌に基づいてテスト品の被験者への有効性を統計解析し、かつ記入催促のメール発送後から被験者のコンピュータによる日誌記入完了までの時間遅れの長短に基づいて日誌記入データの信頼性の低高を評価する、e.仲介者のコンピュータは統計解析結果とデータの信頼性評価結果を記憶し出力する、以上の各工程a〜eを有することを特徴とするコンピュータを用いた被験者管理方法、により達成される。 According to the present invention, a first object is a subject management method using a computer for managing, via the Internet, subjects who cooperate in a clinical trial conducted based on a request from a clinical trial sponsor, comprising: a. The mediator's computer creates a study plan based on the details of the request from the sponsor, and a diary in which the subject is provided with fields for meal content, test product intake, smoking / drinking, exercise, and health status changes. Create and store formats and schedules, b. The mediator computer sends the trial contents, diary format, schedule, ID, and PW stored in the mediator computer to the subject computer via the Internet, c. The presence or absence of the diary input information from the subject of computer input daily for each entry column of the diary format confirmed intermediary computer every day, shortly fill reminder to the subject of the computer on which the non-input, d. Of intermediary computer, and statistical analysis of the effectiveness of the subject of the test product on the basis of a diary in which a large number of subjects entered completion, and from the mail after dispatch fill reminder to the diary entry completed by the subject of computer time delay of Evaluate low or high reliability of diary entry data based on length , e. The intermediary computer is achieved by a subject management method using a computer characterized by having the above steps a to e for storing and outputting statistical analysis results and data reliability evaluation results.
また第2の目的は、請求項1の方法の実施に用いる仲介者のコンピュータであって、治験依頼者の依頼を受けてこの依頼内容に基づいて被験者のコンピュータに送る治験計画および食事内容、テスト品の摂取状況、喫煙・飲酒の有無、運動量、健康状態の変化の記入欄を設けた日誌フォーマットを作成し記憶すると共に仲介者のコンピュータに記憶した治験内容、日誌フォーマット、治験計画、ID、PWを被験者のコンピュータに送る試験準備部と;被験者のコンピュータとの間で情報の送受を管理し、被験者のコンピュータから毎日入力される日誌入力情報を読込んで日誌を作成し記憶すると共に期限内の日誌記入の有無を毎日確認して記入が無い場合に被験者のコンピュータに記入催促のメールを送り被験者のコンピュータによる日誌記入完了までの時間遅れを記憶するメール送信・日誌管理部と;多数の被験者が入力した記入済みの日誌に基づきテスト品の被験者への有効性の統計解析を行い治験結果報告を作成し、さらに、日誌の期限内記入状況を分析し被験者ごとの信頼性評価データを作成して記憶し治験結果報告と共に出力する統計解析部と、を備えることを特徴とするコンピュータを用いた被験者管理装置、により達成される。 A second object is a computer of an intermediary used in the implementation of the method of claim 1, and receives a request from a clinical trial client and sends it to the subject's computer based on the content of the clinical trial plan, meal content, and test. Create and store a diary format with entry fields for product intake status, presence / absence of smoking / drinking, exercise amount, change in health status , clinical trial contents, diary format, clinical trial plan, ID, PW The test preparation department that sends the information to the subject's computer; manages the sending and receiving of information between the subject's computer, reads the diary input information entered daily from the subject's computer, creates and stores the diary, and the diary within the deadline send an e-mail of fill reminder to the subject of the computer in case the presence or absence of the entry there is no entry to check daily diary by the subject of computer E-mail transmission and diary management section that memorizes the time delay until admission completion; statistical analysis of the effectiveness of the test article on the subject based on the completed diary entered by a large number of subjects; And a statistical analysis unit that analyzes and records reliability evaluation data for each subject and analyzes and outputs the results together with a clinical trial result report, by a subject management device using a computer, Achieved.
請求項1の発明によれば、仲介者の端末(コンピュータ、サーバ)は、治験計画に基づいて作成した日誌フォーマットを各被験者の端末(コンピュータ)に送り、被験者はこの日誌フォーマット(以下単に日誌ともいう)に必要事項、例えば食事内容、喫煙、飲酒の有無、運動量、健康状態の変化、等を毎日記入して仲介者端末に返送する。このため仲介者端末では毎日被験者の治験進捗状況を日誌から直ちに把握できる。また仲介者端末は必要に応じて被験者端末に指示の変更、例えば投与間隔の変更を送ることもできるから能率良く管理できる。 According to the invention of claim 1, the intermediary terminal (computer, server) sends a diary format created based on the clinical trial plan to each subject's terminal (computer). The necessary information such as meal contents, smoking, alcohol consumption, amount of exercise, changes in health status, etc. are entered every day and returned to the mediator terminal. For this reason, the intermediary terminal can immediately grasp the clinical trial progress of the subject from the diary every day . Moreover, since the intermediary terminal can send an instruction change, for example, a change in administration interval, to the subject terminal as necessary, it can be managed efficiently.
また日誌に未入力すなわち記入漏れがあれば仲介者端末はこれを確認して被験者端末に記入催促のメールを送るから、記入漏れのない日誌を作成でき、信頼性が向上する。さらに仲介者端末では、各被験者端末から毎日送られて来る日誌の入力内容に基づいてテスト品の被験者への有効性を統計処理および解析を行い、その結果を出力するから治験依頼者に対して速やかに報告できる。さらに日誌記入欄への記入遅れに基づいて入力データの信頼性を評価する。すなわち日時経過に伴って記憶が不明確になることを利用してデータの信頼性を評価でき、治験結果の評価に用いることができる。 If there is no entry in the diary, that is, if there is omission, the mediator terminal confirms this and sends an e-mail prompting entry to the subject terminal, so that a diary with no omission can be created and reliability is improved. Furthermore, the mediator terminal performs statistical processing and analysis on the effectiveness of the test item to the subject based on the input contents of the diary sent from each subject terminal every day , and outputs the result to the trial sponsor. Can report promptly. Furthermore, the reliability of the input data is evaluated based on the delay in filling in the diary entry field. That is, the reliability of data can be evaluated by using the fact that the memory becomes unclear as time passes, and it can be used for evaluation of clinical trial results.
請求項6の発明によればこの方法の実施に直接使用する装置が得られる。 According to the invention of claim 6 , an apparatus used directly for carrying out this method is obtained.
仲介者端末は、被験者端末から送られて来る日誌に未記入部分がある時に、記入催促のメールを被験者端末に送るが、この時の被験者端末からの対応から日誌記入データの信頼性を評価するのがよい(請求項2、9)。この評価は、記入漏れの指摘から記入完了までの遅れ時間や経過日数(記入漏れ日数)、だけであってもよいし、遅れ時間と記入漏れの頻度(催促メールの発送回数)とを併用するものであってもよい(請求項2)。 When there is an unfilled part in the diary sent from the subject terminal, the intermediary terminal sends an email prompting entry to the subject terminal, and evaluates the reliability of the diary entry data from the response from the subject terminal at this time (Claims 2 and 9). This evaluation, serial delay time and number of days to complete entry from the point out of the input leakage (omissions days), may be only, combination and frequency of delay time and omissions (dispatch number of reminder e-mail) may be one which (claim 2).
記入催促のメールは、日誌未入力状態の継続に対して段階的に警告レベルを上げるのが望ましい(請求項3)。例えば最初はメールで丁寧に連絡し、2回目はもっと厳しい条件を付けて(ペナルティを付す旨の通知を付けるなどして)連絡し、3回目は電話で、4回目は携帯メールで連絡するなどが考えられる。 Mail entry prompt, raise a stepwise warning level for continuing diary non-input state desired (claim 3). For example, contact carefully by email first, contact the second with more stringent conditions (for example, with a notice that a penalty will be attached), contact the third by phone, and contact by mobile email the fourth. Can be considered.
これらの信頼性評価結果は統計解析結果と共に出力し治験依頼者に提出すれば、治験依頼者はこの評価を参照して統計解析結果を利用することができるので、治験結果の信頼性を一層向上させることができる。統計解析結果は、仲介者の端末からインターネットを介して治験依頼者端末へ送るのが望ましい(請求項4)。また一度仲介者端末に出力してから治験依頼者へ送ってもよい。 If these reliability evaluation results are output together with the statistical analysis results and submitted to the sponsor, the sponsor can refer to this evaluation and use the statistical analysis results, thereby further improving the reliability of the trial results. Can be made. The statistical analysis result is preferably sent from the broker's terminal to the trial client terminal via the Internet (claim 4 ). Alternatively, it may be output once to the mediator terminal and then sent to the trial sponsor.
仲介者の端末は、被験者端末から送られてくる日誌記入データの送付の有無を定期的に、例えば毎日一定時刻に確認したり、半日毎に確認し、記入済みを確認すると修正できなくするのがよい(請求項5)。このようにすれば日記データの信頼性が一層向上する。 The intermediary terminal checks whether or not the diary entry data sent from the subject terminal is sent regularly, for example, every day at a certain time, or every half day, and if it is confirmed that it has been entered, it cannot be corrected. (Claim 5 ). In this way, the reliability of the diary data is further improved.
図1は本発明の実施例を示す図、図2は信号・データの流れを示す図、図3は全体動作の流れ図、図4は仲介者のコンピュータ(仲介者端末という)の作業内容を示す一覧図、図5は仲介者端末の構成を示す図である。 FIG. 1 is a diagram showing an embodiment of the present invention, FIG. 2 is a diagram showing a flow of signals and data, FIG. 3 is a flowchart of overall operation, and FIG. 4 is a work content of a mediator computer (referred to as a mediator terminal). FIG. 5 is a diagram showing the configuration of the mediator terminal.
図1において符号10は仲介者のサーバ(仲介者端末機、仲介者のコンピュータ、単に仲介者ともいう)、12は治験依頼者(治験依頼機関)の端末機(コンピュータ)、14(14A、14B、…)は治験実施者(治験実施機関)の端末機(コンピュータ)、16(16A、16B、…)は治験対象となる試験食品等の摂取を行い日誌を記入する被験者の端末機(コンピュータ)である。これらはインターネット18を介して互いに接続されている。なお以下仲介者の端末10は単に仲介者10と、治験依頼者の端末12は単に治験依頼者12と、治験実施者の端末14は単に治験実施者14と、被験者の端末16は単に被験者16と、端末機は単に端末ともいう。 In FIG. 1, reference numeral 10 denotes an intermediary server (intermediary terminal, intermediary computer, also simply referred to as an intermediary), and 12 denotes a terminal (computer) of a clinical trial requester (trial requesting institution), 14 (14A, 14B). ,...) Is the terminal (computer) of the investigator (trial institution), 16 (16A, 16B,...) Is the terminal (computer) of the subject who ingests the test food to be studied and fills in the diary. It is. These are connected to each other via the Internet 18. In the following description, the intermediary terminal 10 is simply the intermediary 10, the trial sponsor terminal 12 is simply the trial sponsor 12, the trial sponsor terminal 14 is simply the trial sponsor 14, and the subject terminal 16 is simply the subject 16. The terminal is also simply called a terminal.
治験実施者の端末機14は被験者の健康診断を実際に行う病院などであって治験依頼者12が直接行う場合など必要が無い時には省くことができる。また仲介者10と治験依頼者12、治験実施者14、被験者16との間のデータの送受信は、暗号通信や、ID(認証コード)や、PW(パスワード)を用いることにより、秘密保持性を高めておくのが望ましい。 The investigator's terminal 14 can be omitted when it is not necessary, for example, in a hospital where the medical examination of the subject is actually performed and when the investigator 12 performs it directly. In addition, data transmission / reception between the mediator 10 and the trial client 12, the trial practitioner 14, and the subject 16 is performed by using encryption communication, ID (authentication code), or PW (password), thereby maintaining confidentiality. It is desirable to keep it high.
治験依頼者(医薬品などの生産者や販売者)12は、新しい大衆薬や新しい食品、サプリメントなどを開発すると治験実施者14を決定する。治験依頼者12が自ら治験実施者14となる場合もある。治験依頼者12は治験の実施計画書(デザイン書)と試験概要書を仲介者12および治験実施者14に提示する(図3のステップS0)。 A clinical trial sponsor (producer or seller of pharmaceuticals or the like) 12 decides a clinical trial practitioner 14 to develop a new popular drug, a new food, a supplement, or the like. In some cases, the clinical trial requester 12 itself becomes the clinical trial practitioner 14. The clinical trial client 12 presents the clinical trial implementation plan (design document) and the test summary document to the mediator 12 and the clinical practitioner 14 (step S0 in FIG. 3).
次に仲介者10は、この治験依頼者10の提示内容に基づいて試験情報を新しく作成する(図2、3のステップS1)。この試験情報は、試験名、試験期間、来院回数、試験の種別、プラセボ(Placebo、疑似薬)の有無、盲検化の有無、事後検査の有無、群数、被験者数、などを設定し、被験者16の選定時などに被験者16等がインターネットを介して検索可能にするものである。 Next, the mediator 10 newly creates test information based on the contents presented by the trial client 10 (step S1 in FIGS. 2 and 3). This study information sets the study name, study period, number of visits, study type, presence / absence of placebo, presence / absence of blinding, presence / absence of post-examination, number of groups, number of subjects, etc. The subject 16 or the like can be searched via the Internet when the subject 16 is selected.
一方仲介者10は、予め登録してある候補者の中からこの試験の管理を依頼する医療機関や医師(試験責任医師)、ドクター(自らが行う場合は試験管理者)を設定する(図4のステップS2)。仲介者10はまた、予め登録した被験候補者の中から適合する被験者16を選出する(図4のステップ3)。すなわち候補者16に仲介者10が提供する前記試験情報を示して治験の内容を理解させ、治験に納得し承諾したことを確認する。 On the other hand, the mediator 10 sets medical institutions, doctors (examination doctors), and doctors (examination managers in the case of their own) who request management of this test from candidates registered in advance (FIG. 4). Step S2). The mediator 10 also selects a suitable subject 16 from among the test candidates registered in advance (step 3 in FIG. 4). That is, the trial information provided by the mediator 10 is shown to the candidate 16 so that the contents of the clinical trial can be understood, and it is confirmed that the clinical trial is accepted and accepted.
仲介者10は被験者16が記入する日誌のフォーマット(日誌フォーマット)を作成する(図3、図4のステップS4)。この日誌フォーマットは治験依頼者12の希望や治験内容に基づいて作成する。この日誌フォーマットは、試験食品の摂取状況、回数、食事の内容、お酒、他の薬、他の健康食品、他のサプリメントの摂取の有無、運動実施の有無、体調変化、その他の気付いた体調上の変化、等記入欄を設ける。 The intermediary 10 creates a diary format (diary format) to be filled in by the subject 16 (step S4 in FIGS. 3 and 4). This diary format is created based on the request of the clinical trial client 12 and the content of the clinical trial. This diary format includes test food intake status, number of meals, dietary content , alcohol, other medicines, other health foods, whether or not other supplements are used, whether or not exercise is performed, physical condition changes, and other noticed physical conditions. The above change, etc. column is provided.
仲介者10は被験者16とインターネットを介して被験者16が希望するスケジュールを確認したうえで、スケジュールの設定を行う(図3、4のステップS5、6、7)、すなわち被験者16毎に試験スケジュールと、日誌スケジュールと、来院スケジュールとを設定する。そしてスケジュールに対応した日付、日程などを記入した日誌、すなわち被験者ごとの日誌を表示可能な状態にしたうえで、日誌を被験者の端末16に出力し表示するためのアドレスを被験者16に送る(図3、4のステップS8)。またこれと共にIDやPWを送ってもよい。 The intermediary 10 confirms the schedule desired by the subject 16 via the subject 16 and the Internet, and then sets the schedule (steps S5, 6, and 7 in FIGS. 3 and 4). Set up a diary schedule and a visit schedule. Then, a diary in which the date and schedule corresponding to the schedule are entered, that is, a diary for each subject is made displayable, and an address for outputting and displaying the diary on the subject's terminal 16 is sent to the subject 16 (see FIG. 3, 4 steps S8). Also, an ID or PW may be sent together with this.
仲介者10は治験の開始の日程に従って、被験者16へ薬や食品、サプリメントなどの治験の対象となるものを摂取するのを促したり、日誌への記入を促すメールを予め設定されたスケジュールに従って自動送信する(図3、4のステップS9)。被験者16は指定された日誌(仲介者10のホームページから読出した日誌に)に必要事項を入力する(ステップS10)。 The mediator 10 automatically prompts the subject 16 to take the subject of the trial, such as drugs, foods, supplements, etc., according to the start date of the trial, or automatically sends an email prompting entry to the diary according to a preset schedule. Transmit (step S9 in FIGS. 3 and 4). The subject 16 inputs necessary items to the designated diary (in the diary read from the home page of the broker 10) (step S10).
仲介者10は被験者16による日誌記入が正しい期日にあるいは期限内に入力されているか否かを確認し、全ての項目の記入が済んでいる日誌に対しては確認の処理を行い(ステップS11)、その後の訂正は不可能にする(ステップS11′)。この時未記入事項がある場合には、仲介者10は被験者16に対して催促メールを自動発信する(ステップS12)。この催促メールは記入期限を過ぎて一定時間過ぎると自動発信するように設定しておく。それでも一定時間以上記入が行われない時は、段階的に強いメッセージを送るようにしてもよい。またある段階からは電話で直接連絡したり、携帯メールに連絡してもよい。 The intermediary 10 checks whether or not the diary entry by the subject 16 has been entered on the correct date or within the deadline, and performs a confirmation process on the diary for which all items have been completed (step S11). Thereafter, the correction is made impossible (step S11 ′). If there is an unfilled item at this time, the mediator 10 automatically sends a reminder email to the subject 16 (step S12). This reminder mail is set so that it will be automatically sent when the entry deadline has passed and a certain time has passed. If there is still no entry for a certain period of time, a strong message may be sent step by step. Also, from a certain stage, you may contact directly by phone or contact mobile mail.
また入力が済み確定処理(S11′)した日程の日誌(確定処理済みの日誌)の内容は、治験依頼者12や治験実施者14が確認することができる。すなわち日誌入力状況は仲介者10だけでなく治験依頼者12や治験実施者14でもチェックできることになる(Wチェック、ステップS13)。このため被験者16の体調変化を即日または翌日に知ることができ、被験者16の速やかな保護が可能になり、信頼性向上に適する。 Further, the contents of the diary (diary that has been confirmed) for the schedule that has been input and confirmed (S11 ') can be confirmed by the trial requester 12 and the trial practitioner 14. That is, the diary input status can be checked not only by the mediator 10 but also by the clinical trial requester 12 and the clinical practitioner 14 (W check, step S13). For this reason, the physical condition change of the subject 16 can be known on the same day or the next day, and the subject 16 can be quickly protected, which is suitable for improving the reliability.
全てのスケジュールの日程が終わり、全ての日誌記入項目の入力が完了すると日誌は完成となる(ステップS14)。この場合には仲介者10は日誌のデータを全てまたは必要項目を選択してダウンロード可能とする(ステップS15)。仲介者10は多数の被験者16の日誌データを統計処理し、すなわちテスト品の被験者への有効性などの解析を行う(ステップS16)。また仲介者10は、被験者16による日誌入力が遅れたデータについてはその遅れを確認でき、この遅れが長い程被験者16の記憶が曖昧であって信頼性が低いデータであると判断できる。従ってこの信頼性の低いデータを削除したり、この被験者16のデータを除外するなどの対応をとったうえで報告書を提出する(ステップS17)。 When the schedule of all schedules is completed and the input of all the diary entry items is completed, the diary is completed (step S14). In this case, the broker 10 can download all the diary data or select necessary items (step S15). The intermediary 10 performs statistical processing on the diary data of a large number of subjects 16, that is, analyzes the effectiveness of the test product on the subjects (step S16). Further, the intermediary 10 can confirm the delay of data for which the diary input by the subject 16 is delayed, and it can be determined that the longer the delay, the more ambiguous the memory of the subject 16 and the lower the reliability. Therefore, after taking measures such as deleting the data with low reliability or excluding the data of the subject 16, a report is submitted (step S17).
以上の動作は、図2に示すように処理が順次行われる。この図2で(0)〜(17)は図3、4におけるステップS0〜S17に対応する。 The above operations are sequentially performed as shown in FIG. In FIG. 2, (0) to (17) correspond to steps S0 to S17 in FIGS.
仲介者端末10は以上の種々の処理を行うために図5に示す機能を備える。すなわち試験準備部10Aは、データや日誌フォーマットやID、PWなどの送受信を行うための準備(S8)、試験情報の作成(ステップS1)、日誌フォーマット作成(S2、4)を行う。被験者登録部10Bでは、予めメモリした候補者の中から選出した治験に適する被験者を登録する(ステップS3)。 The intermediary terminal 10 has the functions shown in FIG. 5 in order to perform the various processes described above. That is, the test preparation unit 10A prepares for transmission / reception of data, diary format, ID, PW, etc. (S8), creates test information (step S1), and creates a diary format (S2, 4). In the subject registration unit 10B, subjects suitable for the clinical trial selected from candidates stored in advance are registered (step S3).
メール送信・日誌管理部10Cは、選出された被験者16に対してスケジュールの照会(S5、6、7)、入力状況のチェック(S11、11′)、未記入者への催促(S12)、入力状況のチェック(S13)および日誌完成の確認(S14〜15)や、メール送受信回数、日誌入力時刻管理などを行う。統計解析(信頼性評価)部10Dは、日誌入力済みデータを統計処理し、解析すると共に、メール送信回数、時刻管理により信頼性評価を行う。信頼性評価のためのデータは、催促メールの送信回数や、日誌入力時刻、日誌入力の遅れなどから作成する。この信頼性評価データは、統計解析結果と共に治験依頼者12に送られ、治験結果の評価に用いられる。制御部10Eはこの仲介者端末10の各部10A〜10Dの全体を制御する。またメモリ部10Fは各部10A〜10Eのデータなどを記憶する。 The mail transmission / diary management unit 10C checks the schedule (S5, 6, 7), checks the input status (S11, 11 '), prompts the unfilled person (S12), and inputs the selected subject 16 Status check (S13) and diary completion confirmation (S14-15), the number of times of mail transmission / reception, diary input time management, etc. are performed. The statistical analysis (reliability evaluation) unit 10D statistically processes and analyzes the diary input data, and performs reliability evaluation based on the number of times of mail transmission and time management. Data for reliability evaluation is created from the number of times the reminder mail is sent, the diary entry time, the diary entry delay, and the like. This reliability evaluation data is sent to the clinical trial sponsor 12 together with the statistical analysis result, and is used for evaluation of the clinical trial result. The control unit 10E controls the entire units 10A to 10D of the mediator terminal 10. The memory unit 10F stores data of the units 10A to 10E.
10 仲介者端末(コンピュータ)
10A 試験準備部
10B 被験者登録部
10C メール送信・日誌管理部
10D 統計解析(信頼性評価)部
10E 制御部
10F メモリ部
12 治験依頼者端末(コンピュータ)
14 治験実施者端末(コンピュータ)
16 被験者端末(コンピュータ)
10 Broker terminal (computer)
10A Test preparation unit 10B Subject registration unit 10C Mail transmission / diary management unit 10D Statistical analysis (reliability evaluation) unit 10E Control unit 10F Memory unit 12 Clinical trial client terminal (computer)
14 Clinical trial operator terminal (computer)
16 Subject terminal (computer)
Claims (6)
a.仲介者のコンピュータは治験依頼者の依頼内容に基づいて治験計画を作成すると共に被験者に食事内容、テスト品の摂取状況、喫煙・飲酒の有無、運動量、健康状態の変化の記入欄を設けた日誌フォーマットとスケジュールを作成し記憶する、
b.仲介者のコンピュータはインターネットを介して仲介者のコンピュータに記憶した治験内容、日誌フォーマット、スケジュール、ID、PWを被験者のコンピュータに送る、
c.被験者のコンピュータから前記日誌フォーマットの記入欄ごとに毎日入力される日誌入力情報の有無を仲介者のコンピュータが毎日確認し、未入力がある被験者のコンピュータに対して記入催促のメールを送る、
d.仲介者のコンピュータは、多数の被験者が入力完了した日誌に基づいてテスト品の被験者への有効性を統計解析し、かつ記入催促のメール発送後から被験者のコンピュータによる日誌記入完了までの時間遅れの長短に基づいて日誌記入データの信頼性の低高を評価する、
e.仲介者のコンピュータは統計解析結果とデータの信頼性評価結果を記憶し出力する、
以上の各工程a〜eを有することを特徴とするコンピュータを用いた被験者管理方法。 A test subject management method using a computer for managing a subject who cooperates in a trial based on a request of a trial sponsor via the Internet,
a. The mediator's computer creates a study plan based on the details of the request from the sponsor, and a diary in which the subject is provided with fields for meal content, test product intake, smoking / drinking, exercise, and health status changes. Create and store formats and schedules,
b. The mediator computer sends the trial contents, diary format, schedule, ID, and PW stored in the mediator computer to the subject computer via the Internet.
c. The presence or absence of the diary input information from the subject of computer input daily for each entry column of the diary format confirmed intermediary computer every day, shortly fill reminder to the subject of the computer on which the non-input,
d. Of intermediary computer, and statistical analysis of the effectiveness of the subject of the test product on the basis of a diary in which a large number of subjects entered completion, and from the mail after dispatch fill reminder to the diary entry completed by the subject of computer time delay of Evaluate low or high reliability of diary entry data based on length
e. The intermediary computer stores and outputs statistical analysis results and data reliability evaluation results.
A subject management method using a computer, characterized by having the above steps a to e.
治験依頼者の依頼を受けてこの依頼内容に基づいて被験者のコンピュータに送る治験計画および食事内容、テスト品の摂取状況、喫煙・飲酒の有無、運動量、健康状態の変化の記入欄を設けた日誌フォーマットを作成し記憶すると共に仲介者のコンピュータに記憶した治験内容、日誌フォーマット、治験計画、ID、PWを被験者のコンピュータに送る試験準備部と;
被験者のコンピュータとの間で情報の送受を管理し、被験者のコンピュータから毎日入力される日誌入力情報を読込んで日誌を作成し記憶すると共に期限内の日誌記入の有無を毎日確認して記入が無い場合に被験者のコンピュータに記入催促のメールを送り被験者のコンピュータによる日誌記入完了までの時間遅れを記憶するメール送信・日誌管理部と;
多数の被験者が入力した記入済みの日誌に基づきテスト品の被験者への有効性の統計解析を行い治験結果報告を作成し、さらに、日誌の期限内記入状況を分析し被験者ごとの信頼性評価データを作成して記憶し治験結果報告と共に出力する統計解析部と、
を備えることを特徴とするコンピュータを用いた被験者管理装置。 An intermediary computer used to implement the method of claim 1, comprising:
A diary with columns for the study plan and meal contents to be sent to the subject's computer based on the contents of the request, the intake status of the test product, the presence or absence of smoking / drinking, the amount of exercise, and the change in health status A study preparation section that creates and stores the format and sends the study content, diary format, study plan, ID, and PW stored on the mediator computer to the subject computer;
Controls the sending and receiving of information to and from the subject's computer, reads the diary input information entered daily from the subject's computer, creates and stores the diary, and checks the diary entry within the deadline every day to check whether or not there is no entry An email sending / diary management unit that sends a reminder email to the subject's computer and stores the time delay until completion of diary entry by the subject's computer;
Statistical analysis of the effectiveness of test products on test subjects based on completed diaries entered by a large number of subjects, and preparation of clinical trial results reports A statistical analysis unit that creates, stores and outputs the results together with the clinical trial report,
A test subject management apparatus using a computer comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007292378A JP4463300B2 (en) | 2007-11-09 | 2007-11-09 | Subject management method and apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007292378A JP4463300B2 (en) | 2007-11-09 | 2007-11-09 | Subject management method and apparatus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009116829A JP2009116829A (en) | 2009-05-28 |
| JP2009116829A5 JP2009116829A5 (en) | 2009-07-09 |
| JP4463300B2 true JP4463300B2 (en) | 2010-05-19 |
Family
ID=40783874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007292378A Active JP4463300B2 (en) | 2007-11-09 | 2007-11-09 | Subject management method and apparatus |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4463300B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5073008B2 (en) * | 2010-04-30 | 2012-11-14 | 株式会社ヒューマ | Subject recruitment method, mediator server, software, recording medium |
| JP7509353B2 (en) * | 2019-04-04 | 2024-07-02 | 学校法人帝京大学 | Human testing methods and programs used to carry them out |
| KR102386414B1 (en) * | 2020-11-10 | 2022-04-15 | 이희영 | Apparatus and method for reporting a violation of a clinical trial |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1185727A (en) * | 1997-09-08 | 1999-03-30 | Nippon Telegr & Teleph Corp <Ntt> | Survey method for conducting a questionnaire electronically via a communication network and device used for the same |
| JP2001338100A (en) * | 2000-05-26 | 2001-12-07 | Ec Watch.Com:Kk | Evaluation apparatus, evaluation method, and recording medium storing evaluation software |
| JP2003323489A (en) * | 2002-04-30 | 2003-11-14 | Moss Institute Co Ltd | Visit management system and information processing apparatus, visit management method and program |
| US20030220831A1 (en) * | 2002-05-21 | 2003-11-27 | Lifevine, Inc. | System and method of collecting surveys remotely |
| JP4090320B2 (en) * | 2002-09-30 | 2008-05-28 | 富士通株式会社 | Distribution information management method and information management server |
| JP2004133754A (en) * | 2002-10-11 | 2004-04-30 | Canon Inc | Questionnaire collection system |
| JP2004216666A (en) * | 2003-01-14 | 2004-08-05 | Suzuken Co Ltd | Health information recording sheet and health information entry device |
| JP2004246842A (en) * | 2003-02-13 | 2004-09-02 | Yutaka Oyamada | Market survey method based on generation of market survey objective person model using paid member as objective person |
| US20070276694A1 (en) * | 2003-09-17 | 2007-11-29 | Astellas Pharma Inc. | Medicine Research Information Collection System and Medicine Research Information Collection Program |
| JP2005309604A (en) * | 2004-04-19 | 2005-11-04 | Digital Dream:Kk | Interview-type personal information management method |
| JPWO2005122033A1 (en) * | 2004-06-08 | 2008-07-31 | 有喜 北岡 | Medical integrated information device and integrated medical information system |
| JPWO2007023818A1 (en) * | 2005-08-22 | 2009-03-26 | 国立大学法人 岡山大学 | Real-time information collection / user support system and server control program used therefor |
| JP2007226504A (en) * | 2006-02-23 | 2007-09-06 | Fujitsu Ltd | Evaluation apparatus, evaluation method, and evaluation program |
-
2007
- 2007-11-09 JP JP2007292378A patent/JP4463300B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009116829A (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sinha et al. | Looking through a different lens: patient satisfaction with telemedicine in delivering pediatric fracture care | |
| Kane-Gill et al. | Expansion of telemedicine services: telepharmacy, telestroke, teledialysis, tele–emergency medicine | |
| Zullig et al. | Ingredients of successful interventions to improve medication adherence | |
| Barnes et al. | Making sure the residents get their tablets: medication administration in care homes for older people | |
| US20140249850A1 (en) | Critical condition module | |
| Adaji et al. | The use of information technology to enhance diabetes management in primary care: a literature review. | |
| EP2585986A1 (en) | Medication compliance system and method | |
| JP2007500902A (en) | System and method for documentation of encounters and communication of the documents | |
| Coe et al. | Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review | |
| Reidt et al. | Integrating a pharmacist into a home healthcare agency care model: impact on hospitalizations and emergency visits | |
| Ovbiagele et al. | Mobile health medication adherence and blood pressure control in recent stroke patients | |
| Faisal et al. | The usability, acceptability, and functionality of smart oral multidose dispensing systems for medication adherence: a scoping review | |
| JP2010287237A (en) | Physician instruction management system using communication network | |
| Leon et al. | Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa | |
| Sim et al. | The use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives | |
| JP4463300B2 (en) | Subject management method and apparatus | |
| Lamplot et al. | Good comes from evil: COVID-19 and the advent of telemedicine in orthopedics | |
| JP6954966B2 (en) | Pharmacy cooperation system and method | |
| Kirby et al. | Target product profiles for neonatal care devices: systematic development and outcomes with NEST360 and UNICEF | |
| Lebar et al. | Role of nursing in telehealth | |
| JP6781302B2 (en) | Prescription information transmission system, patient information management server, information transmission method and program | |
| KR20230117932A (en) | Mobile Questionnaire System and Method Linked to Electronic Medical Recording Device | |
| JP2016212829A (en) | Pharmacy support device used by medical information management system and pharmacy support method used by the same device | |
| JP2021026640A (en) | Support system for having family pharmacy | |
| JP2021068420A (en) | Information processing device, information processing method, and program |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090518 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090518 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20090518 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20090603 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090630 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090826 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090930 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091211 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091211 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20100106 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100204 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100216 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4463300 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130226 Year of fee payment: 3 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140226 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |